Abstract
Human recombinant interleukin-1 (HrIL-1) inhibited WEHI-3B cell growth in a dose-related manner (10–10000 U/ml). Prostaglandin E2 at high concentrations (1000 ng/ml) also inhibited cell growth. When added together, HrIL-1 and prostaglandin E2 inhibited WEHI-3B growth in a synergistic manner (HrIL-1 concentrations of 10–10000 U/ml and prostaglandin E2 concentrations of 10–1000 ng/ml). In contrast to the effects of the cyclooxygenase metabolite of arachidonic acid leukotriene C4, a lipoxygenase metabolite, reversed the cytostatic action of HrIL-1.
Keywords: Cell Growth, Cancer Research, Prostaglandin, Arachidonic Acid, Inhibit Cell Growth
References
- 1.Dinarello CA, Marnoy SO, Rosenwasser LJ. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte activating factor/interleukin-1. J Immunol. 1983;130:890. [PubMed] [Google Scholar]
- 2.Dinarello CA, Bishai I, Rosenwasser LJ, Coceani F. The influence of lipoxygenase inhibitors on the in vitro production of human leukocyte pyrogen and lymphocyte activating factor (interleukin-1) Int J Immunopharmacol. 1984;6:43. doi: 10.1016/0192-0561(84)90033-x. [DOI] [PubMed] [Google Scholar]
- 3.Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RN, Webb AC, Auron PE, Ruben RC, Rich A, Wolff SM, Putney SD. Multiple biological activities of human recombinant interleukin-1. J Clin Invest. 1986;77:1734. doi: 10.1172/JCI112495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Farrar WL, Humes JL. The role of arachidonic acid metabolism in the activities of interleukin-1. J Immunol. 1985;135:1153. [PubMed] [Google Scholar]
- 5.Kennedy MS, Stobo JD, Goldyne ME. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. Prostaglandins. 1980;20:135. doi: 10.1016/0090-6980(80)90013-1. [DOI] [PubMed] [Google Scholar]
- 6.Kunkel SL, Chensue SW, Phan SH. Prostaglandins as endogenous modulators of interleukin-1 production. J Immunol. 1986;136:186. [PubMed] [Google Scholar]
- 7.Levine L, Morgan RA, Lewis RA, Austen KF, Clark DA, Marfat A, Corey EJ. Radioimmunoassay of the leukotrienes of slow reacting substance of anaphalaxis. Proc Natl Acad Sci USA. 1981;78:7692. doi: 10.1073/pnas.78.12.7692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Metcalf D, Nicola NA. Autoinduction of differentiation in WEHI-3B leukemia cells. Int J Cancer. 1982;30:773. doi: 10.1002/ijc.2910300616. [DOI] [PubMed] [Google Scholar]
- 9.Miller AM, Weiner RS, Ziboh VA. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp Hematol. 1986;14:760. [PubMed] [Google Scholar]
- 10.Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J Immunol. 1985;135:3962. [PubMed] [Google Scholar]
- 11.Ophir R, Ben-Efraim S, Bonta IL. Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumor cells. Int J Tissue React. 1987;9:189. [PubMed] [Google Scholar]
- 12.Rola-Pleszcznski M, LeMaire I. Leukotrienes augment interleukin-1 production by human monocytes. J Immunol. 1985;135:3958. [PubMed] [Google Scholar]
- 13.Schenkelaars EJ, Bonta IL. Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses. Int J Immunopharmacol. 1986;8:305. doi: 10.1016/0192-0561(86)90112-8. [DOI] [PubMed] [Google Scholar]
- 14.Shahabi NA, Chegini JL, Wittliff JL. Alterations of MCF-7 human breast cancer cell after prostaglandin A1 and PGF2a treatment. Exp Cell Biol. 1987;55:18. [PubMed] [Google Scholar]
- 15.Tamatani T, Urawa H, Hashimoto T, Onozaki K. Tumor necrosis factor as an interleukin-1-dependent differentiation inducing factor (D-factor), for mouse myeloid leukemic cells. Biochem Biophys Res Commun. 1987;143:390. doi: 10.1016/0006-291x(87)90678-4. [DOI] [PubMed] [Google Scholar]